Crossmark

Characteristics and management of multiple sclerosis patients during the Omicron era: is there a concern about the MS course in the face of the new variant of COVID-19?

Crossref DOI link: https://doi.org/10.1007/s10072-022-06447-4

Published Online: 2022-10-18

Published Print: 2023-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Paybast, Sepideh

Habibi, Mohammad Amin

Naser Moghadasi, Abdorreza https://orcid.org/0000-0002-8598-0911
License Information

Text and Data Mining valid from 2022-10-18

Version of Record valid from 2022-10-18
More Information

Article History

Received: 12 July 2022

Accepted: 6 October 2022

First Online: 18 October 2022

Declarations

:

: The authors declare no competing interests.

: None.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below